 |
| Marcelo Di Carli, MD |
Marcelo Di Carli, MD, chief in the Division of Nuclear Medicine and Molecular Imaging in the Department of Radiology and director of the Cardiovascular Imaging Program in Radiology and the Department of Medicine, was selected for the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2019 Georg Charles de Hevesy Nuclear Medicine Pioneer Award.
Each year, SNMMI presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual for outstanding contributions to the field of nuclear medicine. Dr. De Hevesy received the 1943 Nobel Prize in chemistry for his work in determining the absorption, distribution, metabolism and elimination of radioactive compounds in the human body. His work led to the foundation of nuclear medicine as a tool for diagnosis and therapy. SNMMI has given the de Hevesy Award every year since 1960 to honor groundbreaking discoveries and inventions in the field of nuclear medicine.
Di Carli specializes in cardiovascular imaging. His research primarily focuses on cardiovascular diseases, including coronary heart disease, heart failure and pulmonary arterial hypertension. He is the principal investigator of several ongoing clinical trials using noninvasive cardiovascular imaging, including a multicenter, federally funded study evaluating the effects of anti-inflammatory therapy on coronary flow reserve and cardiac mechanics in patients with diabetes and coronary heart disease. He is also the program director of a National Institutes of Health T32 training grant in cardiovascular imaging research.
Headquartered in Reston, Va., SNMMI is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging.
